1. Home
  2. SNY vs CDNS Comparison

SNY vs CDNS Comparison

Compare SNY & CDNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • CDNS
  • Stock Information
  • Founded
  • SNY 1994
  • CDNS 1988
  • Country
  • SNY France
  • CDNS United States
  • Employees
  • SNY N/A
  • CDNS N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • CDNS Computer Software: Prepackaged Software
  • Sector
  • SNY Health Care
  • CDNS Technology
  • Exchange
  • SNY Nasdaq
  • CDNS Nasdaq
  • Market Cap
  • SNY 116.5B
  • CDNS 95.3B
  • IPO Year
  • SNY N/A
  • CDNS 1987
  • Fundamental
  • Price
  • SNY $49.58
  • CDNS $342.81
  • Analyst Decision
  • SNY Buy
  • CDNS Strong Buy
  • Analyst Count
  • SNY 3
  • CDNS 15
  • Target Price
  • SNY $65.00
  • CDNS $360.33
  • AVG Volume (30 Days)
  • SNY 2.3M
  • CDNS 1.4M
  • Earning Date
  • SNY 10-24-2025
  • CDNS 10-27-2025
  • Dividend Yield
  • SNY 3.23%
  • CDNS N/A
  • EPS Growth
  • SNY 118.56
  • CDNS N/A
  • EPS
  • SNY 8.65
  • CDNS 3.70
  • Revenue
  • SNY $53,714,621,258.00
  • CDNS $5,089,287,000.00
  • Revenue This Year
  • SNY $2.01
  • CDNS $15.31
  • Revenue Next Year
  • SNY $6.82
  • CDNS $12.13
  • P/E Ratio
  • SNY $11.21
  • CDNS $92.61
  • Revenue Growth
  • SNY 15.65
  • CDNS 22.30
  • 52 Week Low
  • SNY $44.73
  • CDNS $221.56
  • 52 Week High
  • SNY $60.12
  • CDNS $376.45
  • Technical
  • Relative Strength Index (RSI)
  • SNY 51.60
  • CDNS 47.94
  • Support Level
  • SNY $50.07
  • CDNS $343.11
  • Resistance Level
  • SNY $51.60
  • CDNS $355.49
  • Average True Range (ATR)
  • SNY 0.61
  • CDNS 6.65
  • MACD
  • SNY 0.00
  • CDNS -1.75
  • Stochastic Oscillator
  • SNY 40.06
  • CDNS 18.45

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About CDNS Cadence Design Systems Inc.

Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enables system-level analysis and verification solutions.

Share on Social Networks: